Circulating FGF23 linked to incident coronary heart disease

March 9, 2018

(HealthDay)—Higher circulating fibroblast growth factor 23 (FGF23) concentrations are associated with an increased risk of incident coronary heart disease (CHD), according to a study published online March 7 in JAMA Cardiology.

Bhupesh Panwar, M.D., from the University of Alabama at Birmingham, and colleagues examined the association of FGF23 concentrations with incident CHD risk within the Reasons for Geographic and Racial Differences in Stroke study. In a case-control design, data were measured in 829 participants who developed incident CHD and in 812 randomly selected participants.

The researchers found that higher FGF23 concentrations at baseline were seen in association with greater age, lower estimated , higher urine albumin to creatinine ratio, and female sex. After adjustment for established CHD risk factors and kidney function, higher FGF23 concentrations were correlated with increased risk of CHD (hazard ratio comparing fourth with first quartile, 2.15). The magnitude and strength of these correlations varied by gender. After adjustment for in women (hazard ratio comparing fourth with first quartile: 2.4 for men and 2.34 for women, respectively) or when using sex-specific FGF23 quartiles (hazard ratio comparing fourth with first quartile: 2.65 and 2.26 for men and women, respectively), these differences were no longer observed.

"Heterogeneity in the association by sex may be caused by differences in the distribution of plasma FGF23 concentrations or the use of hormone therapy in men versus ," the authors write.

Two authors disclosed financial ties to pharmaceutical companies, including Amgen, which provided funding for the study.

Explore further: High-risk plaque on coronary CTA linked to future MACE

More information: Abstract/Full Text

Related Stories

High-risk plaque on coronary CTA linked to future MACE

January 11, 2018
(HealthDay)—For outpatients with stable chest pain, high-risk plaque found by coronary computed tomographic angiography (CTA) is associated with subsequent major adverse cardiovascular events (MACE), according to a study ...

NTproBNP levels are significantly lower in blacks

November 23, 2017
(HealthDay)—Plasma N-terminal pro-B-type natriuretic peptide (NTproBNP) levels are significantly lower for black than white individuals, according to a study published online Nov. 22 in JAMA Cardiology.

Stem cell factor tied to reduced risk of cardiac events, death

September 1, 2017
(HealthDay)—High levels of stem cell factor (SCF) are associated with reduced risk of mortality and cardiovascular events, according to a study published online Aug. 26 in the Journal of Internal Medicine.

Ablation cuts risk of recurrent stroke in patients with A-fib

November 28, 2017
(HealthDay)—For patients with atrial fibrillation (AF) and prior cerebrovascular accident (CVA), ablation is associated with reduced risk of recurrent stroke, according to a study published online Nov. 13 in the Journal ...

Microvascular endothelial dysfunction can predict dementia

April 22, 2017
(HealthDay)—Markers of microvascular endothelial dysfunction can predict dementia, according to a study published online April 13 in the Journal of Internal Medicine.

Recommended for you

Increasing statins dose and patient adherence could save more lives

December 7, 2018
Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors.

Progress made in transplanting pig hearts into baboons

December 6, 2018
A large team of researchers from several institutions in Germany, Sweden, Switzerland and the U.S. has transplanted pig hearts into baboons and kept them alive for an extended period of time. In their paper published in the ...

Obesity ups survival in heart failure, but that's no reason to pile on pounds

December 6, 2018
(HealthDay)—Obese people with heart failure may live longer than those who are thinner—especially if they are "metabolically healthy," a new study suggests.

New genetic insight could help treat rare debilitating heart and lung condition

December 6, 2018
The largest study of genetic variation in patients with pulmonary arterial hypertension has associated two important genes with the disease.

New drug target discovered for potential blood pressure treatment

December 5, 2018
Scientists have identified a key player in blood pressure regulation and have shown that switching it off reduces blood pressure in mice, according to new research in eLife.

Neighborhoods with more green space may mean less heart disease

December 5, 2018
People who live in leafy, green neighborhoods may have a lower risk of developing heart disease and strokes, according to new research published in the Journal of the American Heart Association, the Open Access Journal of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.